<SEC-DOCUMENT>0001213900-19-017687-index.html : 20190911 <SEC-HEADER>0001213900-19-017687.hdr.sgml : 20190911 <ACCEPTANCE-DATETIME>20190911103721 ACCESSION NUMBER: 0001213900-19-017687 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20190905 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190911 DATE AS OF CHANGE: 20190911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCELL CORP /DE/ CENTRAL INDEX KEY: 0000811641 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010382980 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12934 FILM NUMBER: 191087506 BUSINESS ADDRESS: STREET 1: 56 EVERGREEN DR CITY: PORTLAND STATE: ME ZIP: 04103 BUSINESS PHONE: 2078782770 MAIL ADDRESS: STREET 1: 56 EVERGREEN DRIVE CITY: PORTLAND STATE: ME ZIP: 04103 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>f8k090519_immucellcorp.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: f8k090519_immucellcorp.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>f8k090519ex99-1_immucellcorp.htm <DESCRIPTION>PRESS RELEASE OF THE COMPANY DATED SEPTEMBER 11, 2019 <TEXT> Document 2 - file: f8k090519ex99-1_immucellcorp.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>f8k090519ex99-2_immucellcorp.htm <DESCRIPTION>DEVELOPMENT SERVICES AND COMMERCIAL SUPPLY AGREEMENT BETWEEN THE COMPANY AND NORBROOK LABORATORIES, LIMITED DATED SEPTEMBER 5, 2019 <TEXT> Document 3 - file: f8k090519ex99-2_immucellcorp.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>4 <FILENAME>f8k090519ex99-3_immucellcorp.htm <DESCRIPTION>TERMINATION AGREEMENT BETWEEN THE COMPANY AND NORDSON CORPORATION DATED SEPTEMBER 10, 2019 <TEXT> Document 4 - file: f8k090519ex99-3_immucellcorp.htm
</DOCUMENT> </SEC-DOCUMENT>